PARTNERING

We Bring Antibacterial Wound dressings for Uumed Medical Needs.

DermaMaxx offers breakthrough solutions for massive unmet needs and major Wound care markets. We are eager to meet strategic partners and investors to ensure these innovations are made available to all the patients who need them.

Chronic wounds, such as Diabetic Foot Ulcers, venous leg ulcers, and pressure ulcers, contribute major costs to healthcare systems and societies. Just in the USA, 8.2 million patients are impacted annually by non-healing wounds and related complications. The global market for chronic wound care is estimated at 10 billion USD, with a 5% annual growth rate, revealing a need for better treatment options than the ones currently available. The outcome of the Phase 1 & 2 study in Diabetic Foot Ulcers makes us confident that we can change the treatment paradigm of chronic wounds.

ARE YOU INTERESTED IN BECOMING AN INVERSTOR OR STRATEGIC PARTNER?

GET TOUCH WITH US!